Ilizarov treatment of congenital pseudarthroses of the tibia

K J Guidera1, E M Raney, T Ganey

  • 1Shriners Hospital for Children, Tampa, Florida 33612-9499, USA.

Insights

The Ilizarov device effectively treated congenital pseudarthrosis of the tibia in most pediatric patients. Amputation is a consideration for persistent non-union cases after Ilizarov treatment.

Area of Science:

  • Orthopedic surgery
  • Pediatric orthopedics
  • Limb reconstruction

Background:

  • Congenital pseudarthrosis of the tibia (CPT) is a rare, challenging pediatric bone condition.
  • Effective treatment strategies for CPT remain an area of significant clinical interest.
  • The Ilizarov external fixation device offers a method for limb lengthening and deformity correction.

Observation:

  • Eleven pediatric patients diagnosed with CPT underwent treatment using the Ilizarov device.
  • The study details the treatment duration, number of subsequent surgical procedures, and outcomes.
  • Patient follow-up data was collected to assess the efficacy of the intervention.

Findings:

  • The Ilizarov device achieved successful union in 9 out of 11 pediatric patients.
  • Successful treatment required an average of 322 days with the external fixator and 1.6 additional surgeries.
  • Two patients ultimately required amputation due to persistent non-union.

Implications:

  • The Ilizarov device represents a viable and effective treatment option for congenital pseudarthrosis of the tibia in children.
  • Amputation should be considered as a salvage procedure when Ilizarov treatment fails to achieve bone union, especially after prior surgical attempts.
  • Further research may explore factors predicting successful Ilizarov treatment outcomes in CPT.

Related Concept Videos